Clinical Trials

Breast Cancer

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 10 of 14 Clinical Trials Related to Breast Cancer

Clinical Research Trial

Amgen 757 Lung Cancer

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306)

Clinical Research Trial

NRG-BR009 Breast Cancer

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal

Doctor(s) Running This Study
Clinical Research Trial

SWOG S2010 Breast Cancer

A Randomized Phase III Trial Comparing Active Symptom Monitoring Plus Patient Education Versus Patient Education Alone to Improve Persistence With Endocrine Therapy in Young Women With Stage I-III Breast Cancer

Doctor(s) Running This Study
Clinical Research Trial

A012103 Breast Cancer

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Doctor(s) Running This Study
Clinical Research Trial

EAY191-N2 Breast Cancer

PHASE 2 TRIAL OF FULVESTRANT AND BINIMETINIB IN PATIENTS WITH HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER WITH A FRAMESHIFT OR NONSENSE MUTATION OR GENOMIC DELETION IN NF1

Doctor(s) Running This Study
Clinical Research Trial

S1706 Breast

A Phase II Randomized Trial of Olaparib Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer

Doctor(s) Running This Study
Clinical Research Trial

MSK 21-183 Breast Cancer

Selective Use of ALND in cT1-2N1 HR+/HER2- Breast Cancer Patients with 1 or 2 Positive Sentinel Lymph Nodes Undergoing Upfront Surgery and Adjuvant Radiation: A Prospective Study

Doctor(s) Running This Study
Clinical Research Trial

A011801 Breast Cancer

THE COMPASSHER2 TRIALS (COMPREHENSIVE USE OF PATHOLOGIC RESPONSE ASSESSMENT TO OPTIMIZE THERAPY IN HER2-POSITIVE BREAST CANCER): COMPASSHER2 RESIDUAL DISEASE (RD), A DOUBLE-BLINDED, PHASE III RANDOMIZED TRIAL OF T-DM1 AND PLACEBO

Doctor(s) Running This Study
Clinical Research Trial

S1501

Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III

Doctor(s) Running This Study
Clinical Research Trial

NRG-BR004

A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

Doctor(s) Running This Study